Because it has been demonstrated that metformin inhibits mitochondrial complex I activity13, we speculated that metformin may prevent Erk1/2 phosphorylation via decreased ATP generation to attenuate cancer cell growth. This evidence concerns the gene MAPK3 and cancer.